-+ 0.00%
-+ 0.00%
-+ 0.00%

ALLARITY THERAPEUTICS DOSES FIRST PATIENTS IN VA-FUNDED PHASE 2 TRIAL FOCUSED ON SMALL CELL LUNG CANCER WITH HIGH UNMET NEED

Reuters·02/18/2026 13:15:00

Please log in to view news